Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.

Ayumi YoshifujiMasataro TodaMunekazu RyuzakiKan KikuchiToru KawaiKen SakaiEmi OyamaMasayoshi KoinumaKazuhiko KatayamaYuki UeharaNorio OhmagariYoshihiko KannoHirofumi KonToshio ShinodaYaoko TakanoJunko TanakaKazuhiko HoraYasushi NakazawaNaoki HasegawaNorio HanafusaFumihiko HinoshitaKeita MorikaneShu WakinoHidetomo NakamotoYoshiaki Takemoto

Published in: Renal replacement therapy (2022)

HD patients had significantly lower antibody titers than age- and sex-matched non-dialysis individuals over 3 months after vaccination. Dialysis time was identified as a factor affecting SARS-CoV-2 IgG titers in HD group, with longer dialysis time resulting in higher maximum SARS-CoV-2 IgG titers.

Keyphrases

end stage renal disease
chronic kidney disease
sars cov
peritoneal dialysis
respiratory syndrome coronavirus
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes